Skip to main content

The Advanced
Lab Request

Standard blood panels routinely miss the underlying drivers of metabolic dysfunction. Hand this guide to your primary care provider to ensure accurate tracking and metabolic preservation during your GLP-1 therapy.

✉️ Email Guide
The Clinical Anchor
NIH: Apolipoprotein B vs. LDL in Cardiovascular Risk →
NIH: High-Sensitivity C-Reactive Protein and Metabolic Syndrome →

The Top 5 Metabolic Markers

The Mechanism: Rapid weight loss on incretin mimetics alters lipid metabolism, systemic inflammation, and thyroid function. You must track active hormones and specific lipoproteins, not just generalized cholesterol and blood sugar.

The Requested Panel
  • Fasting Insulin: Standard panels check A1C and glucose, but Fasting Insulin reveals how hard your pancreas is working to maintain those numbers, giving you the earliest indicator of reversing insulin resistance.
  • ApoB (Apolipoprotein B): LDL cholesterol is an outdated metric for cardiovascular risk. ApoB measures the actual particle count of atherogenic lipoproteins, which is the most accurate predictor of heart health during rapid fat mobilization.
  • hs-CRP (High-Sensitivity C-Reactive Protein): This measures systemic, low-grade inflammation. Tracking hs-CRP allows you to quantify the direct anti-inflammatory benefits of your GLP-1 therapy beyond the scale.
  • GGT (Gamma-Glutamyl Transferase): This is a highly sensitive, early indicator of liver stress. It is critical for tracking how effectively your body is clearing visceral organ fat as you lose weight.
  • Free T3 (Triiodothyronine): Unlike a standard TSH test, Free T3 measures the actual active thyroid hormone available to your cells. Monitoring this prevents the metabolic slowdown and severe plateaus commonly caused by caloric deficits.